FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Gray Market Peptides: So Much Hype, So Little Data FDA Compliance for Peptide Therapy and BPC 157 Holt Law